HOME >> BIOLOGY >> NEWS
Improving livestock health, trade and human livelihoods in Africa

Boston -- In many parts of Africa, livestock are not only a source of food, but also an underutilized trading commodity. Working with international and regional agencies, Africa-based researchers from Feinstein International Center (FIC) at Tufts University address policies and practices to improve animal health and trade in local communities, including constraints around the export of livestock and livestock products. Andrew Catley, PhD, a research director at FIC, contributed to a "Viewpoint" article in the July 8th issue of The Veterinary Record that highlights the need for a trustworthy and viable process to certify the status of livestock commodities as a means to encourage safe export trade. An earlier paper by Catley and colleagues addresses the underlying issue of improving health care services for livestock, a challenge in parts of Africa where a dearth of veterinary services hinders efforts.

"Increasing international trade of livestock is a potentially useful poverty reduction strategy for developing regions, particularly Africa, but there are many obstacles that hinder that trade," says Catley. The authors of the Veterinary Record Viewpoint, including lead author G.R. Thomson, emphasize the need for an independent source of certification based on improved international standards to benefit livestock farmers in Africa.

"Under the current World Trade Organization standards that govern international trade of animals and animal products, trade from developing regions to countries like the United States and European nations is hindered because of concerns about government veterinary services in developing countries. These services are often weak and in some countries, are affected by high levels of corruption, yet they're responsible for issuing international health certificates for livestock exports," explains Catley. Importing countries "need verification that there is minimal risk of infectious disease agents that threaten human healt
'"/>

Contact: Siobhan Gallagher
617-636-6586
Tufts University
26-Jul-2006


Page: 1 2 3

Related biology news :

1. Improving plants abilities to cope with saline conditions
2. Spotlight on liver disease: Improving todays treatments
3. Health care reimagined: Improving patient care through early health
4. Improving outcomes in premature births
5. Improving urban environments: why childrens voices should be heard
6. Improving police cars, recovering lost manuscripts: UH research day delivers
7. Improving the potential of cancer vaccines
8. Improving artificial heart top goal of award-winning research at UH
9. AAAS panel will focus on the impact of livestock production on the planet
10. Killing wolves may not protect livestock efficiently
11. Chemical Society Boston meeting, Aug. 19-23, focuses on health, wellness, energy, environment

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Improving livestock health trade and human livelihoods Africa

(Date:7/23/2015)... 2015 Aware, Inc. (NASDAQ: AWRE ), a ... results for its second quarter ended June 30, 2015.  ... $4.5 million, a decrease of 33% compared to $6.8 million ... second quarter of 2015 was $0.3 million, or $0.01 per ... diluted share, in the same period a year ago.  ...
(Date:7/21/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology from ... also the user using unique personal identifiers including ...
(Date:7/13/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ... today announced sampling of ClearPad ® 4300, ... (TDDI) product targeting smartphones and tablets. This new ... , best-in-class touch controller IP and systems ... in the company,s Japan Design Center. TDDI enables ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3
(Date:7/30/2015)... (PRWEB) , ... July 31, 2015 , ... Ralco is ... Center at the Lyon County Fair to be held August 5-9 in Marshall. The ... where their meals come from and how agriculture impacts their daily lives. This unique ...
(Date:7/30/2015)... According to a new market ... PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), ... by End Users - Global Forecast to 2020", published ... USD 2,107.99 million by 2020 from USD 1,034.93 million ... Browse more than 75 ...
(Date:7/30/2015)... COPENHAGEN, Denmark , July 30, 2015 /PRNewswire/ ... a biotechnology company that applies its innovative TransCon ... announced positive top-line results from a six-month Phase ... of once-weekly TransCon Growth Hormone in 53 treatment-naïve, ... "We are extremely pleased with the ...
(Date:7/29/2015)... -- Sanofi, a global and diversified ... of 2015. CEO Olivier Brandicourt comments ... different businesses. Watch video interview and ... Topics covered in the interview include:  ... drivers - Diabetes - ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
Cached News: